304006-18-6

Basic information

• Product Name: 1-Naphthalenesulfonamide, N-[[4-[[[4-chloro-6-[(1-methylethyl)amino]-1,3,5-triazin-2-yl]amino]methyl] cyclohexyl]methyl]-
• CAS NO: 304006-18-6
• Molecular Formula: C24H31ClN6O2S
• Molecular Weight: 503.068
• Mol File: 304006-18-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-Naphthalenesulfonamide, N-[[4-[[[4-chloro-6-[(1-methylethyl)amino]-1,3,5-triazin-2-yl]amino]methyl] cyclohexyl]methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Naphthalenesulfonamide, N-[[4-[[[4-chloro-6-[(1-methylethyl)amino]-1,3,5-triazin-2-yl]amino]methyl] cyclohexyl]methyl]-(304006-18-6)
• EPA Substance Registry System: 1-Naphthalenesulfonamide, N-[[4-[[[4-chloro-6-[(1-methylethyl)amino]-1,3,5-triazin-2-yl]amino]methyl] cyclohexyl]methyl]-(304006-18-6)

Safety Data

• Hazardous Substances Data: 304006-18-6(Hazardous Substances Data)

Upstream product

• 304006-90-4 trans-naphthalene-1-sulfonic acid (4-aminomethylcyclohexylmethyl)-amide 
• 3703-10-4 2,4-dichloro-6-isopropylamino-1,3,5-triazine 

Relevant articles and documents

Selective NPY (Y5) antagonists (triazines)

This invention is directed to triazine derivatives which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.